C12N 2501/2311
Interleukin-11
Official title: Interleukin-11 (IL-11)
C12N2501/2311 (Interleukin-11) appears on 48 US grants and 82 published applications in this corpus.
Search patents in C12N- Granted patents
- 48
- Published applications
- 82
- Assignees
- 53
- Inventors
- 130
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 4 |
| 2015 | 1 | 4 |
| 2016 | 2 | 4 |
| 2017 | 2 | 3 |
| 2018 | 4 | 9 |
| 2019 | 4 | 2 |
| 2020 | 3 | 9 |
| 2021 | 6 | 6 |
| 2022 | 4 | 8 |
| 2023 | 3 | 3 |
| 2024 | 6 | 7 |
| 2025 | 4 | 7 |
| 2026 | 3 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for production of platelets from pluripotent stem cells and compositions thereof4 Aug 2026US RE50,977 E1Astellas Institute for Regenerative Medicine
- Methods for production of platelets from pluripotent stem cells and compositions thereof16 Jun 2026US 12,653,840 B2Astellas Institute for Regenerative Medicine
- Methods for production of platelets from pluripotent stem cells and compositions thereof16 Jun 2026US RE50,916 E1Astellas Institute for Regenerative Medicine
- Single cells pluripotent stem cells in a suspension culture23 Dec 2025US 12,503,684 B2Technion Research & Development Foundation Limited
- Methods and compositions for inducing hematopoietic cell differentiation9 Sep 2025US 12,410,403 B2Fate Therapeutics, Inc.
- Method for isolating hemogenic endothelial cells3 Sep 2026US 2026/0258361 A1Fondazione Telethon Ets
- Pluripotent stem cell-derived megakaryocytes and platelets16 Apr 2026US 2026/0103680 A1c/o Stratus Therapeutics, Inc.
- Erythroid lineages derived from pluripotent cells9 Apr 2026US 2026/0097074 A1Stratus Therapeutics, Inc.
- Methods and compositions for inducing hematopoietic cell differentiation5 Mar 2026US 2026/0062676 A1Fate Therapeutics, Inc.
- Methods of making chimeric antigen receptor-expressing cells26 Feb 2026US 2026/0055157 A1Novartis AG
Most cited
By later US patents
- Embryonic cell populations and methods to isolate such populations111US 5,914,268 ANational Jewish Center for Immunology and Respiratory Medicine · 1999
- Culture medium for avian embryonic cells22US 6,500,668 B22002
- Methods for production of platelets from pluripotent stem cells and compositions thereof18US 9,763,984 B2Astellas Institute for Regenerative Medicine · 2017
- Methods for production of platelets from pluripotent stem cells and compositions thereof17US 10,426,799 B2Astellas Institute for Regenerative Medicine · 2019
- Methods and compositions for inducing hematopoietic cell differentiation17US 10,626,372 B1Fate Therapeutics, Inc. · 2020